Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diodone is a small molecule radiocontrast agent, specifically an ionic monomeric contrast medium that was formerly used for diagnostic imaging procedures, particularly in urography to visualize the urinary tract. It is typically formulated as a salt with diethanolamine and belongs to the class of alpha amino acids and derivatives. Diodone is water-soluble, nephrotropic (targeting the kidneys), and characterized by high osmolarity. Its renal clearance follows supply-limited elimination kinetics. The precise molecular mechanism of action remains unclear, but its function as a contrast agent relies on its iodine content to enhance X-ray imaging by increasing radiopacity in targeted tissues[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diodone.